Deshpande, Devyani <br/><br/>
Moxifloxacin pharmacokinetics/pharmacodynamics and optimal dose and susceptibility breakpoint identification for treatment of disseminated Mycobacterium avium infection.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Jun 2010 
 - 2534-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.01761-09  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--administration & dosage<br/>Area Under Curve<br/>Aza Compounds--administration & dosage<br/>Cell Line<br/>Colony Count, Microbial<br/>Fluoroquinolones<br/>Half-Life<br/>Humans<br/>In Vitro Techniques<br/>Microbial Sensitivity Tests<br/>Models, Biological<br/>Monte Carlo Method<br/>Moxifloxacin<br/>Mycobacterium avium Complex--drug effects<br/>Mycobacterium avium-intracellulare Infection--drug therapy<br/>Protein Binding<br/>Quinolines--administration & dosage